Double click here to edit new New Header component
Investment Bank
How can we help?
Parsys 1
Double click here to edit Hero Media component

Synthetic biology in consumer goods: The next big frontier

authorImage authorImage

Contributor: Galya Laskar

Synthetic biology ("synbio") uses genetic engineering to alter a cell’s DNA to make target molecules for manufacturing use across industries. It already plays a role in healthcare, has shown promise in energy and our Research team believes that consumer goods are the next big frontier. Our team estimates a $50-125bn market opportunity today, yet synbio’s full potential isn’t on investors’ radar.

authorImage authorImage

Contributor: Galya Laskar

Series Image
Rainbow colored DNA helix illustration
Parsys 2
Double click here to edit Go To Section component

Go to Section

Parsys 3
Synthetic biology process illustration
Graphic depicting six roles synthetic biology can play in consumer goods production
Bar chart showing annual funding in USD for synthetic biology ventures from 2009-2020
Important content disclosuresImportant content disclosures
Parsys 4
Double click here to edit Banner component
Parsys 5
Double click here to edit Experts Panel Card component

About the expert

Galya Laskar

Sustainable and Thematic Research

Galya Laskar is a Senior Analyst within Sustainable & Thematic Investing. She joined Barclays' Equity Research department in 2014, supporting coverage of the Packaged Food sector until late 2019. Since early 2020, she has published thematic reports focusing on the Consumer and Healthcare sectors. Prior to joining Barclays, Galya was a Senior Associate at a boutique TMT investment banking firm. Galya started her finance career in 2011 at Nomura where she worked in investment banking. Galya received her B.A. from the University of California, San Diego, where she majored in Urban Studies & Planning and Political Science. She received her M.B.A. from Columbia Business School.

iParsys for Double Pixel component